Nearly 70% of agents say AI makes their work more fulfilling—but only when it's designed to empower them, not replace them. This roundtable explores how leading organizations are transforming the ...

Phase 1 Findings Demonstrated that Investigational Agent AX-158 Was Well Tolerated at All Doses, with a Profile that Strongly Supports Further Clinical Development Efforts AX-158 is Being Developed ...